IPSC icon

Century Therapeutics

0.7698 USD
+0.1024
15.34%
At close Updated Dec 18, 3:28 PM EST
1 day
15.34%
5 days
30.12%
1 month
57.1%
3 months
51.83%
6 months
31.28%
Year to date
-25.98%
1 year
-26.69%
5 years
-96.63%
10 years
-96.63%
 

About: Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Employees: 165

0
Funds holding %
of 7,523 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™